SSW
GILD icon

Stone Summit Wealth’s Gilead Sciences GILD Stock Holding History

Stone Summit Wealth’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.87M Sell
30,669
-577
-2% -$76K 0.98% 34
2026
Q1 		$4.35M Sell
31,246
-1,311
-4% -$184K 1.21% 25
2025
Q4 		$4M Sell
32,557
-206
-0.6% -$25K 1.08% 27
2025
Q3 		$3.64M Sell
32,763
-160
-0.5% -$18.2K 1.03% 33
2025
Q2 		$3.65M Buy
32,923
+575
+2% +$61.2K 1.13% 31
2025
Q1 		$3.62M Buy
32,348
+1,845
+6% +$190K 1.23% 27
2024
Q4 		$2.82M Buy
30,503
+1,798
+6% +$162K 0.95% 34
2024
Q3 		$2.41M Buy
28,705
+487
+2% +$37.2K 0.78% 42
2024
Q2 		$1.94M Sell
28,218
-7,254
-20% -$484K 0.69% 48
2024
Q1 		$2.6M Buy
35,472
+1,214
+4% +$93.4K 0.9% 39
2023
Q4 		$2.78M Sell
34,258
-2,312
-6% -$180K 1.06% 28
2023
Q3 		$2.74M Buy
36,570
+2,722
+8% +$209K 1.17% 26
2023
Q2 		$2.61M Buy
33,848
+1,278
+4% +$102K 1.08% 29
2023
Q1 		$2.7M Buy
32,570
+6,950
+27% +$576K 1.2% 24
2022
Q4 		$2.2M Buy
25,620
+2,385
+10% +$189K 1.08% 27
2022
Q3 		$1.43M Buy
23,235
+1,475
+7% +$93K 0.88% 42
2022
Q2 		$1.34M Sell
21,760
-382
-2% -$23.7K 0.8% 45
2022
Q1 		$1.32M Buy
22,142
+6,907
+45% +$442K 0.74% 45
2021
Q4 		$1.11M Buy
+15,235
New +$1.05M 0.9% 43

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Stone Summit Wealth's GILD Position: Q2 2026 in Review

Stone Summit Wealth reduced its Gilead Sciences (GILD) stake by 1.8% in Q2 2026, selling an estimated $76K and leaving 30,669 shares worth $3.87M. The position accounts for 0.98% of the portfolio, ranked #34.

Stone Summit Wealth first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.35M in Q1 2026. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Stone Summit Wealth held 30,669 shares of Gilead Sciences worth $3.87M as of Q2 2026.
  • Stone Summit Wealth sold 577 Gilead Sciences shares in Q2 2026, an estimated $76K.
  • Gilead Sciences made up 0.98% of Stone Summit Wealth's portfolio in Q2 2026, its #34 holding.
  • Stone Summit Wealth first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
  • Stone Summit Wealth's Gilead Sciences position peaked at $4.35M in Q1 2026.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Stone Summit Wealth's 13F filing for Q2 2026, filed 23 Jul 2026.